Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C17H23NO2 |
Molecular Weight | 273.37 |
Optical Activity | ( + ) |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)[C@@]1(CCC=C[C@H]1N(C)C)C2=CC=CC=C2
InChI
InChIKey=WDEFBBTXULIOBB-WBVHZDCISA-N
InChI=1S/C17H23NO2/c1-4-20-16(19)17(14-10-6-5-7-11-14)13-9-8-12-15(17)18(2)3/h5-8,10-12,15H,4,9,13H2,1-3H3/t15-,17+/m1/s1
Molecular Formula | C17H23NO2 |
Molecular Weight | 273.37 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15627429
The selectivity of tilidine and nortilidine for human opioid and opioid-like receptors stably expressed in CHO-K1 cells, using the inhibition of the forskolin (FK)-induced accumulation of cAMP as the endpoint was measured. In cells expressing the Mu opioid receptor, tilidine and nortilidine inhibited cAMP accumulation with IC50 of 11 microM and 110 nM, respectively.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:17:13 GMT 2023
by
admin
on
Fri Dec 15 17:17:13 GMT 2023
|
Record UNII |
2728MV084C
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C67413
Created by
admin on Fri Dec 15 17:17:13 GMT 2023 , Edited by admin on Fri Dec 15 17:17:13 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
30131
Created by
admin on Fri Dec 15 17:17:13 GMT 2023 , Edited by admin on Fri Dec 15 17:17:13 GMT 2023
|
PRIMARY | |||
|
100000083453
Created by
admin on Fri Dec 15 17:17:13 GMT 2023 , Edited by admin on Fri Dec 15 17:17:13 GMT 2023
|
PRIMARY | |||
|
77822
Created by
admin on Fri Dec 15 17:17:13 GMT 2023 , Edited by admin on Fri Dec 15 17:17:13 GMT 2023
|
PRIMARY | |||
|
DTXSID9023671
Created by
admin on Fri Dec 15 17:17:13 GMT 2023 , Edited by admin on Fri Dec 15 17:17:13 GMT 2023
|
PRIMARY | |||
|
SUB07049MIG
Created by
admin on Fri Dec 15 17:17:13 GMT 2023 , Edited by admin on Fri Dec 15 17:17:13 GMT 2023
|
PRIMARY | |||
|
2728MV084C
Created by
admin on Fri Dec 15 17:17:13 GMT 2023 , Edited by admin on Fri Dec 15 17:17:13 GMT 2023
|
PRIMARY | |||
|
3474
Created by
admin on Fri Dec 15 17:17:13 GMT 2023 , Edited by admin on Fri Dec 15 17:17:13 GMT 2023
|
PRIMARY | |||
|
32447-90-8
Created by
admin on Fri Dec 15 17:17:13 GMT 2023 , Edited by admin on Fri Dec 15 17:17:13 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104560
Created by
admin on Fri Dec 15 17:17:13 GMT 2023 , Edited by admin on Fri Dec 15 17:17:13 GMT 2023
|
PRIMARY | |||
|
251-048-6
Created by
admin on Fri Dec 15 17:17:13 GMT 2023 , Edited by admin on Fri Dec 15 17:17:13 GMT 2023
|
PRIMARY | |||
|
C77376
Created by
admin on Fri Dec 15 17:17:13 GMT 2023 , Edited by admin on Fri Dec 15 17:17:13 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
RACEMATE -> ACTIVE ENANTIOMER |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|